<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04236726</url>
  </required_header>
  <id_info>
    <org_study_id>CRF-QoL</org_study_id>
    <nct_id>NCT04236726</nct_id>
  </id_info>
  <brief_title>Investigating Health Related Quality of Life in Patients With Chronic Respiratory Failure</brief_title>
  <acronym>CRF-QoL</acronym>
  <official_title>Investigating Health Related Quality of Life in Patients With Chronic Respiratory Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guy's and St Thomas' NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the quality of life of patients living with chronic respiratory failure and the
      impact interventions have on it.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 19, 2019</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HRQoL score</measure>
    <time_frame>Day 0: At the first outpatient clinical consultation with the clinical team</time_frame>
    <description>Outcome of various HRQoL assessment tools.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in HRQoL score</measure>
    <time_frame>6 months following first assessment for Outcome 1</time_frame>
    <description>Change in HRQoL assessment tool score at next clinical follow-up.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Respiratory Failure</condition>
  <condition>Neuromuscular Diseases</condition>
  <condition>Ventilatory Failure</condition>
  <arm_group>
    <arm_group_label>Non-invasive ventilation</arm_group_label>
    <description>Users of non-invasive ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Long term tracheostomy ventilation</arm_group_label>
    <description>Long term tracheostomy ventilated patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>HRQoL questionnaires</description>
    <arm_group_label>Non-invasive ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with chronic respiratory failure being treated with a form of ventilation of
        mechanical insufflation-exsufflation therapy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Diagnosed with chronic respiratory failure receiving any of:

          -  Non-invasive ventilation

          -  Prolonged mechanical ventilation

          -  Mechanical insufflation-exsufflation therapy

        Exclusion Criteria:

          -  Aged &lt;18

          -  Significant physical or psychiatric co-morbidity that would prevent compliance with
             trial protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Murphy, MBBS</last_name>
    <role>Study Chair</role>
    <affiliation>Guy's and St Thomas' NHS Foundation Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Neeraj Shah, MBBS</last_name>
    <phone>+442071888070</phone>
    <email>neeraj.shah@gstt.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patrick Murphy, MBBS</last_name>
    <phone>+442071888070</phone>
    <email>patrick.murphy@gstt.nhs.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Guy's and St. Thomas NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neeraj Shah</last_name>
      <email>neeraj.shah@gstt.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Gill Arbane</last_name>
      <email>gill.arbane@gstt.nhs.uk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>December 17, 2019</study_first_submitted>
  <study_first_submitted_qc>January 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2020</study_first_posted>
  <last_update_submitted>January 21, 2020</last_update_submitted>
  <last_update_submitted_qc>January 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Hypoventilation</mesh_term>
    <mesh_term>Neuromuscular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

